97344 ⎘
Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
IgE CH3 peptide vaccine
#602Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
#603DEGRADABLE CLOSTRIDIAL TOXINS
#604Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
#605Recombinant pokeweed antiviral proteins, compositions and methods related thereto
#606Multimeric protein toxins to target cells having multiple identifying characteristics
#607Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
#608SUPPRESSION OF CANCER
#609Bacterial toxin vaccine
#610Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies
#611Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
#612CD20 antibodies and uses thereof
#613CD20 antibodies and uses thereof
#614MATERIALS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY AND TAXANE-INDUCED PERIPHERAL NEUROPATHY (TIPN)
#615Fiducial markers for augmented reality
#616MINIGENE
#617Oral recombinant vaccine and preparing method thereof
#618TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS
#619Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
#620antigens, vaccine compositions, and related methods
#621Circovirus sequences associated with piglet weight loss disease (PWD)
#622Chimeric proteins and uses thereof
#623GAS57 mutant antigens and GAS57 antibodies
#624Optimized DNA sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
#625Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents
#626Methods and compositions for modulating immune tolerance
#627Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases
#628Use of an anti-Tau pS422 antibody for the treatment of brain diseases
#629Protein delivery system to generate pluripotent stem (iPS) cells or tissue specific cells
#630Toxin peptide therapeutic agents
#631COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#632COMPLEXING SYSTEM
#633Circovirus sequences associated with piglet weight loss disease (PWD)
#634Recombinant toxin fragments
#635ENGINEERING ZYMOGEN FOR CONDITIONAL TOXICITY
#636Human anti-mesothelin monoclonal antibodies
#637In vivo unnatural amino acid expression in the methylotrophic yeast
#638Anticancer Combination Therapies
#639Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest
#640Methods and Uses of Anti-IL-23 Antibodies
#641Targeted antimicrobial moieties
#642Expression of Human Serum Albumin in Plastids
#643Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof
#644Cytokine zalpha11 ligand antibodies
#645CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#646Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
#647Optimized nucleic acid sequences for the expression of VB4-845
#648Cytotoxins comprising modified bouganin toxin for the treatment of cancer
#649Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
#650VECTOR ENCODING THERAPEUTIC POLYPEPTIDE AND SAFETY ELEMENTS TO CLEAR TRANSDUCED CELLS
#651CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#652Cytokine zalpha11 ligand antibodies
#653Circovirus sequences associated with piglet weight loss disease (PWD)
#654CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#655CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#656CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#657CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#658NOVEL COMPOSITIONS FOR THE TREATMENT OF VERIOUS INFLAMMATORY CONDITIONS
#659Vaccines Containing Non-Live Antigenic Vectors
#660CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#661Circovirus sequences associated with piglet weight loss disease (PWD)
#662CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#663CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#664CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#665CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#666CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#667CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#668Method for transcription/degradation dual control of protein by antibiotic
#669TARGETED BIOCIDES
#670Circovirus sequences associated with piglet weight loss disease (PWD)
#671METHODS OF TREATING BONE DISEASE USING VASCULAR ENDOTHELIAL GROWTH FACTOR FUSION CONSTRUCTS
#672Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
#673Immunotoxins for the treatment of diseases related to CMV infection
#674Insecticidal toxin complex fusion protiens
#675Use of human cells of myeloid leukaemia origin for expression of antibodies
#676Recombinant toxin fragments
#677Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer
#678Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain
#679Vaccine comprising recombinant ct or lt toxin
#680CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#681Treatment of metastatic tumors
#682HERV-K ANTIGENS, ANTIBODIES, AND METHODS
#683CD33-SPECIFIC SINGLE-CHAIN IMMUNOTOXIN AND METHODS OF USE
#684METHODS AND COMPOSITIONS FOR IMMUNIZING AGAINST PSEUDOMONAS INFECTION
#685Methods and compositions for needleless delivery of macromolecules
#686Recombinant toxin fragments
#687Constructs for delivery of therapeutic agents to neuronal cells
#688Dual Specific Immunotoxin for Brain Tumor Therapy
#689Lytic domain fusion constructs and methods of making and using same
#690IL3Rα antibody conjugates and uses thereof
#691Recombinant toxin fragments
#692Lytic domain fusion constructs and methods of making and using same
#693LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME
#694Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates
#695Shiga toxoid chimeric proteins
#696Serum resistance factors of gram positive bacteria
#697METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES
#698Circovirus sequences associated with piglet weight loss disease (PWD)
#699Anti-IL-23 antibodies, compositions, methods and uses
#700Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
#701PRODUCTION OF CYTOTOXIC ANTIBODY-TOXIN FUSION IN EUKARYOTIC ALGAE
#702Recombinant toxin fragments
#703Circovirus sequences associated with piglet weight loss disease (PWD)
#704Light emitting microorganisms and cells for diagnosis and therapy of tumors
#705Light emitting microorganisms and cells for diagnosis and therapy of tumors
#706Light emitting microorganisms and cells for diagnosis and therapy of tumors
#707Light emitting microorganisms and cells for diagnosis and therapy of tumors
#708Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies
#709Immunoglobulin Directed Biocides
#710Circovirus sequences associated with piglet weight loss disease (PWD)
#711Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereof
#712TRANSGENIC PLANT-BASED VACCINES
#713Methods for generating and screening fusion protein libraries and uses thereof
#714Therapeutic use of anti-tweak receptor antibodies
#715Human monoclonal antibodies to O8E
#716Degradable clostridial toxins
#717ACTIVATABLE CLOSTRIDIAL TOXINS
#718Optimized DNA and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
#719SKIN IMMUNIZATION USING LT-STA FUSION PROTEINS
#720TOXIN COMPOUNDS WITH ENHANCED MEMBRANE TRANSLOCATION CHARACTERISTICS
#721Rhabdoviral N-Fusion Proteins as Carrier for Foreign Antigens
#722Carcinoembryonic antigen fusions and uses thereof
#723Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
#724Viral/bacterial toxin polypeptides and methods of using same
#725Method of Controlling Insects and Virus Transmission
#726Protein constructs designed for targeting and lysis of cells
#727Methods and compositions involving polymeric immunoglobulin fusion proteins
#728Recombinant fusion protein and polynucleotide construct for immunotoxin production
#729Chimeric proteins, their preparation and pharmaceutical compositions containing them
#730Chloroplasts Engineering to Express Pharmaceutical Proteins
#731Antimicrobial Peptide Biocides
#732Combined immunological agent and sensitizing agent for the treatment of cancer
#733Innate Immune Receptor Directed Biocides
#734Methods And Compositions For Grafting Functional Loops Into A Protein
#735DNA vaccine
#736Circovirus sequences associated with piglet weight loss disease (PWD)
#737Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album
#738Modified bouganin proteins, cytotoxins and methods and uses thereof
#739AMINO ACID SUBSTITUTED MOLECULES
#740Degradable clostridial toxins
#741Tweak-pseudomonas exotoxin a fusion protein for cancer therapy
#742Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells
#743Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
#744Process for production of diphtheria toxin
#745DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#746Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate
#747Isolated complexes of covalently cross-linked endotoxin and modified MD-2
#748Modified human interferon-β polypeptides
#749Hybrid Shiga-like toxin
#750Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
#751HERV-K Antigens, Antibodies, and Methods
#752Library of Toxin Mutants, and Methods of Using Same
#753CD44E tumor specific antibody
#754Vaccines
#755Circovirus sequences associated with piglet weight loss disease (PWD)
#756Recombinant toxin fragments
#757Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
#758Methods for promoting, inhibiting and detecting toxin entry into cells
#759Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
#760Rice plant having vaccine gene transferred thereinto
#761Recombinant toxin fragments
#762Cytokine zalpha11 ligand fusion proteins
#763Hybrid proteins of active-site serine β-lactamase
#764Circovirus sequences associated with piglet weight loss disease (PWD)
#765CYTOKINE ZALPHA11 LIGAND
#766CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#767CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#768Toxin peptide therapeutic agents
#769Cytokine zalpha11 ligand fusion proteins
#770Cytokine zalpha11 ligand fusion proteins
#771Circovirus sequences associated with piglet weight loss disease (PWD)
#772Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#773Circovirus sequences associated with piglet weight loss disease (PWD)
#774Circovirus sequences associated with piglet weight loss disease (PWD)
#775Cytokine zalpha11 ligand antibodies and methods of use
#776Antigen of hybrid M protein and carrier for group a streptococcal vaccine
#777Methods of using cytokine zalpha11 ligand
#778CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#779Circovirus sequences associated with piglet weight loss disease (PWD)
#780Cytokine zalpha11 ligand fusion proteins
#781Method of use of cytokine ZALPHA11 ligand
#782Circovirus sequences associated with piglet weight loss disease (PWD)
#783Circovirus sequences associated with piglet weight loss disease (PWD)
#784CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#785Cytokine zalpha11 ligand antibodies
#786Anti-IL-23 antibodies, compositions, methods and uses
#787Transgenic plant-based vaccines
#788Multiepitope polypeptides for cancer immunotherapy
#789Hetero type pentamer recombinant vaccine
#790Nucleotide sequence for treating cancer and infection
#791Circovirus sequences associated with piglet weight loss disease (PWD)
#792Compositions and methods for enhancing the immunogenicity of antigens
#793VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment
#794Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
#795Insecticidal toxin complex fusion proteins
#796Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses
#797Methods and compositions for needleless delivery of macromolecules
#798Biosynthetic binding proteins for immuno-targeting
#799Methods for constructing antibiotic resistance free vaccines
#800Super-antigen fusion proteins and the use thereof
#801Insect viruses and their uses in protecting plants
#802Recombinant toxin fragments
#803Methods and compositions for immunizing against Pseudomonas infection
#804Compositions and methods for modifying toxic effects of proteinaceous compounds
#805Circovirus sequences associated with piglet weight loss disease (PWD)
#806Vaccines for suppressing ige-mediated allergic disease and methods for using the same
#807Process for production diphtheria toxin
#808Transgenically produced fusion proteins
#809Toxin compounds with enhanced membrane translocation characteristics
#810Insect viruses and their uses in protecting plants
#811Multimeric protein toxins to target cells having multiple identifying characteristics
#812Recombinant toxin fragments
#813Modified bouganin proteins, cytotoxins and methods and uses thereof
#814Plasmids encoding therapeutic agents
#815Insect viruses and their uses in protecting plants
#816Novel method of diagnosing and treating gliomas
#817Intein-mediated protein ligation of expressed proteins
#818Circovirus sequences associated with piglet weight loss disease (PWD)
#819Vaccinia virus for diagnosis and therapy of tumors
#820Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis
#821Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
#822Targeted biocides
#823Circovirus sequences associated with piglet weight loss disease (PWD)
#824Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
#825Chimeric protein toxins for expression by therapeutic bacteria
#826Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#827Molecules that bind to SARS-CoV-2
#828Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
#829Immunization and/or treatment of parasites and infectious agents by live bacteria